Mon, March 27, 2023

Raghuram Selvaraju Reiterated (ADMA) at Strong Buy and Held Target at $4.5 on, Mar 27th, 2023

Raghuram Selvaraju of HC Wainwright & Co., Reiterated "ADMA Biologics, Inc." (ADMA) at Strong Buy and Held Target at $4.5 on, Mar 27th, 2023.

Raghuram, nor any peers, have made any analyst calls on ADMA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30